Mr Darquin Chiu, PHARMD, MAOM | |
335 Broadway, Cambridge, MA 02139-1803 | |
(617) 849-0208 | |
Not Available |
Full Name | Mr Darquin Chiu |
---|---|
Gender | Male |
Speciality | Acupuncturist |
Location | 335 Broadway, Cambridge, Massachusetts |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1033557327 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | 233109 (Massachusetts) | Secondary |
171100000X | Acupuncturist | (Massachusetts) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mr Darquin Chiu, PHARMD, MAOM 335 Broadway, Cambridge, MA 02139-1803 Ph: (617) 849-0208 | Mr Darquin Chiu, PHARMD, MAOM 335 Broadway, Cambridge, MA 02139-1803 Ph: (617) 849-0208 |
News Archive
Stroke injures the brain, but a new University of South Florida study indicates an abdominal organ that plays a vital role in immune function, the spleen, may be a target for treating stroke-induced chronic inflammation leading to further brain cell death.
Electronic prescribing (e-prescribing) systems that allow doctors to select lower cost or generic medications can save $845,000 per 100,000 patients per year and possibly more system-wide, according to findings from a new study funded by HHS' Agency for Healthcare Research and Quality.
Proteostasis Therapeutics and Elan Corporation today announced a strategic business relationship to advance Proteostasis' platform for the discovery and development of disease-modifying, small molecule drugs and diagnostics for the treatment of neurodegenerative disorders such as Parkinson's, Huntington's, multiple sclerosis and amyotrophic lateral sclerosis, and a broad array of dementia-related diseases including Alzheimer's.
Cancer Research UK today (Thursday) launches a new Centre which will accelerate the pace of research in Glasgow and see the city become a world leader in the development of new treatments tailored for individual cancer patients.
› Verified 4 days ago